Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEAmalgamation/MergerM&A1 Oct 2026

TVS Supply Chain Solutions Limited

Amalgamation/Merger

TVS Supply Chain Solutions Limited has received sanction from the Hon'ble National Company Law Tribunal, Bengaluru Bench for the Scheme of Amalgamation with SPC International (India) Private Limited, paving the way for the Scheme to become effective upon filing of certified copies of the orders with the jurisdictional Registrar of Companies.

Read more →📎 1 attachment
NSEUpdates▲ PositiveM&A1 Oct 2026

Jagsonpal Pharmaceuticals Limited

Updates

Jagsonpal Pharmaceuticals Limited has completed the acquisition of Group Pharmaceuticals' wellness portfolio, a strategic move to strengthen its wellness portfolio and create opportunities for cross-selling.

Read more →📎 1 attachment
BSECompany UpdateM&A1 Oct 2026

Hitech Corporation Ltd-$

Intimation of publication of reasoned recommendations of Independent Directors'' Committee on Voluntary Delisting as per Regulation 28 of SEBI Delisting Regulations.

Hitech Corporation Ltd has announced the publication of the reasoned recommendations of the Independent Directors' Committee on the voluntary delisting offer made by Geetanjali Trading and Investments Private Limited to acquire up to 43,91,220 equity shares representing 25.57% of the company's equity share capital.

Read more →📎 1 attachment
BSECompany UpdateM&A1 Oct 2026

IDream Film Infrastructure Company Ltd

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform that the as per the Scrutinizer report dated 30th September, 2026 received on 1st October, 2026, members of the Company at the Annual General Meeting held on 29th September, 2026, have approved the alteration of the Object Clause of the Memorandum of Association of the Company and adoption of a ....

IDream Film Infrastructure Company Ltd has informed about the alteration of the Object Clause of the Memorandum of Association and adoption of a new set of Memorandum of Association and Articles of Association, as approved by the shareholders at the Annual General Meeting held on 29th September, 2026.

Read more →📎 1 attachment
NSEAcquisitionM&A1 Oct 2026

Sudarshan Chemical Industries Limited

Acquisition

Sudarshan Chemical Industries Limited has completed the acquisition of 36,68,036 equity shares of Sudarshan Colorants India Limited, constituting 15.89% of the total share capital, for an aggregate consideration of INR 150,75,62,796.

Read more →📎 1 attachment
NSEGeneral UpdatesM&A1 Oct 2026

Wipro Limited

General Updates

Wipro Limited has completed the acquisition of select customer contracts of Alpha Net Consulting LLC and its subsidiaries, as per the definitive agreement signed earlier.

Read more →📎 1 attachment
BSECompany UpdateM&A1 Oct 2026

Wipro Ltd

Please refer to our earlier letters dated April 15, 2026, June 23, 2026, and September 30, 2026, respectively informing that Wipro Limited, through its subsidiaries, had signed a definitive agreement to acquire select customer contracts of Alpha Net Consulting LLC and its subsidiaries and that the transaction was expected to be completed by December 31, 2026. In continuation to the aforesaid letters, it is hereby informed that the said transaction has been completed on October 1, 2026.

Wipro Ltd has completed the acquisition of select customer contracts of Alpha Net Consulting LLC and its subsidiaries, as announced earlier.

Read more →📎 1 attachment
BSECompany UpdateM&A1 Oct 2026

Amalgamated Electricity Company Ltd

Outcome of BM

Amalgamated Electricity Company Ltd's board meeting held on October 1, 2026, approved changes to the company's object clause, issuance of equity shares to non-promoter investors, and other matters.

Read more →📎 1 attachment
NSEAcquisitionM&A1 Oct 2026

Aurobindo Pharma Limited

Acquisition

Aurobindo Pharma Limited has informed the Exchange about the acquisition of 100% stake in A1 Biochem Labs (India) Private Limited by Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company. As part of the terms agreed under the definitive agreements, Dr. Rajendra Gadikota, former promoter of A1 Biochem group, has subscribed to 89,94,500 equity shares and 2,41,05,500 Compulsory Convertibles Debentures of A1 Labs, equaling to 20% stake (on a fully diluted basis).

Read more →📎 1 attachment
← PreviousPage 54 of 181Next →